Literature DB >> 23687579

Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose Nevirapine With or Without Zidovudine for Prevention of Mother-to-Child Transmission.

Soren Gantt1, Rachel Payant2, Jacquelyn Carlsson2, Mark A Micek3, Ana Judith Blanco3, Ingrid A Beck2, Laurinda Matunha4, Pablo Montoya3, Eduardo Matediana5, Stephen Gloyd3, Lisa M Frenkel6.   

Abstract

Among 30 human immunodeficiency virus type 1 (HIV-1)-infected women who received single-dose nevirapine (NVP), 17 (57%) had NVP-resistant HIV-1 detected in breast milk. NVP resistance in breast milk persisted for at least 8 months postpartum and was apparently transmitted to at least 1 infant. NVP resistance was detected less often in women who also received zidovudine.
© The Author 2012. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2012        PMID： 23687579      PMCID： PMC3656540          DOI： 10.1093/jpids/pis065

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


  12 in total

1.  Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.

Authors:  Mark A Micek; Ana Judith Blanco; Ingrid A Beck; Sandra Dross; Laurinda Matunha; Pablo Montoya; Kristy Seidel; Soren Gantt; Eduardo Matediane; Lilia Jamisse; Stephen Gloyd; Lisa M Frenkel
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

2.  Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field.

Authors:  I A Beck; K D Drennan; A J Melvin; K M Mohan; A M Herz; J Alarcón; J Piscoya; C Velázquez; L M Frenkel
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

3.  Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay.

Authors:  Thor A Wagner; Catherine M Kress; Ingrid Beck; Malee Techapornroong; Pakorn Wittayapraparat; Somboon Tansuphasawasdikul; Gonzague Jourdain; Nicole Ngo-Giang-Huong; Marc Lallemant; Lisa M Frenkel
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

4.  Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.

Authors:  Daniel Pilger; Andrea Hauser; Claudia Kuecherer; Kizito Mugenyi; Rose Kabasinguzi; Sybille Somogyi; Gundel Harms; Andrea Kunz
Journal:  Antivir Ther       Date:  2011

5.  Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine.

Authors:  Mark A Micek; Ana Judith Blanco; Jacquelyn Carlsson; Ingrid A Beck; Sandra Dross; Laurinda Matunha; Kristy Seidel; Pablo Montoya; Soren Gantt; Eduardo Matediana; Lilia Jamisse; Stephen Gloyd; Lisa M Frenkel
Journal:  J Infect Dis       Date:  2012-04-05       Impact factor: 5.226

6.  Antiretroviral therapies in women after single-dose nevirapine exposure.

Authors:  Shahin Lockman; Michael D Hughes; James McIntyre; Yu Zheng; Tsungai Chipato; Francesca Conradie; Fred Sawe; Aida Asmelash; Mina C Hosseinipour; Lerato Mohapi; Elizabeth Stringer; Rosie Mngqibisa; Abraham Siika; Diana Atwine; James Hakim; Douglas Shaffer; Cecilia Kanyama; Kara Wools-Kaloustian; Robert A Salata; Evelyn Hogg; Beverly Alston-Smith; Ann Walawander; Eva Purcelle-Smith; Susan Eshleman; James Rooney; Sibtain Rahim; John W Mellors; Robert T Schooley; Judith S Currier
Journal:  N Engl J Med       Date:  2010-10-14       Impact factor: 91.245

7.  Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration.

Authors:  Sarah E Hudelson; Michelle S McConnell; Danstan Bagenda; Estelle Piwowar-Manning; Teresa L Parsons; Monica L Nolan; Paul M Bakaki; Michael C Thigpen; Michael Mubiru; Mary Glenn Fowler; Susan H Eshleman
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

8.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

Authors:  J Brooks Jackson; Philippa Musoke; Thomas Fleming; Laura A Guay; Danstan Bagenda; Melissa Allen; Clemensia Nakabiito; Joseph Sherman; Paul Bakaki; Maxensia Owor; Constance Ducar; Martina Deseyve; Anthony Mwatha; Lynda Emel; Corey Duefield; Mark Mirochnick; Mary Glenn Fowler; Lynne Mofenson; Paolo Miotti; Maria Gigliotti; Dorothy Bray; Francis Mmiro
Journal:  Lancet       Date:  2003-09-13       Impact factor: 79.321

9.  Laboratory indicators of mastitis are not associated with elevated HIV-1 DNA loads or predictive of HIV-1 RNA loads in breast milk.

Authors:  Soren Gantt; Avinash K Shetty; Kristy D Seidel; Kuda Matasa; Georgina Musingwini; Godfrey Woelk; Lynn S Zijenah; David A Katzenstein; Lisa M Frenkel
Journal:  J Infect Dis       Date:  2007-06-29       Impact factor: 5.226

10.  Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.

Authors:  Anitha Moorthy; Amita Gupta; Ramesh Bhosale; Srikanth Tripathy; Jayagowri Sastry; Smita Kulkarni; Madhuri Thakar; Renu Bharadwaj; Anju Kagal; Arvind V Bhore; Sandesh Patil; Vandana Kulkarni; Varadharajan Venkataramani; Usha Balasubramaniam; Nishi Suryavanshi; Carrie Ziemniak; Nikhil Gupte; Robert Bollinger; Deborah Persaud
Journal:  PLoS One       Date:  2009-01-01       Impact factor: 3.240
View more
  2 in total

1.  Transmission of nevirapine-resistant HIV type 1 via breast milk to infants after single-dose nevirapine in Beira, Mozambique.

Authors:  Mark A Micek; Sandra Dross; Ana Judith Blanco; Ingrid A Beck; Laurinda Matunha; Kristy Seidel; Pablo Montoya; Eduardo Matediana; Soren Gantt; Stephen Gloyd; Lisa Frenkel
Journal:  J Infect Dis       Date:  2014-03-04       Impact factor: 5.226

2.  Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique.

Authors:  Francisco Antunes; Pereira Zindoga; Perpétua Gomes; Orvalho Augusto; Isabel Mahumane; Luís Veloso; Emília Valadas; Ricardo Camacho
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.